Synthesis and SAR Studies of 1H-Pyrrolo[2,3-b]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors

ACS Medicinal Chemistry Letters
2020.0

Abstract

Herein we report the synthesis, SAR, and biological evaluation of a series of 1H-pyrrolo[2,3-b]pyridine-2-carboxamide derivatives as selective and potent PDE4B inhibitors. Compound 11h is a PDE4B preferring inhibitor and exhibited acceptable in vitro ADME and significantly inhibited TNF-α release from macrophages exposed to pro-inflammatory stimuli (i.e., lipopolysaccharide and the synthetic bacterial lipopeptide Pam3Cys). In addition, 11h was selective against a panel of CNS receptors and represents an excellent lead for further optimization and preclinical testing in the setting of CNS diseases.

Knowledge Graph

Similar Paper

Synthesis and SAR Studies of 1H-Pyrrolo[2,3-b]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors
ACS Medicinal Chemistry Letters 2020.0
Phosphodiesterase Type IV Inhibition. Structure-Activity Relationships of 1,3-Disubstituted Pyrrolidines
Journal of Medicinal Chemistry 1995.0
Synthesis, Structure−Activity Relationships, and Pharmacological Profile of 9-Amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indoles:  Discovery of Potent, Selective Phosphodiesterase Type 4 Inhibitors
Journal of Medicinal Chemistry 2000.0
Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings
European Journal of Medicinal Chemistry 2016.0
Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and bioactivity of 3,5-dimethylpyrazole derivatives as potential PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2018.0
Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Novel indolizine compounds as potent inhibitors of phosphodiesterase IV (PDE4): structure–activity relationship
Med. Chem. Commun. 2010.0
Design, synthesis and biological evaluation of 2,4-disubstituted oxazole derivatives as potential PDE4 inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect
European Journal of Medicinal Chemistry 2019.0